Efficacy and Safety of Tisagenlecleucel in Patients with Relapsed/Refractory Follicular Lymphoma: A Real-World Analysis from the Center for Blood and Marrow Transplant Research (CIBMTR) Registry

Poster Presentation
© 2024 American Society of Hematology. All rights reserved.
Meeting: 2024 ASH® Annual Meeting
Indication: Follicular Lymphoma (FL)
Presenter: Daniel J. Landsburg, MD
Affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, PA
Presentation Date: December 9, 2024
Abstract Number: 4398
Session: Session: 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III
Related content: Follicular Lymphoma (FL)
Poster Presentation
Abstract Number: 3034
Presenter: Catherine Thieblemont, MD
Indication: Follicular Lymphoma (FL)
Date Presented: December 8, 2024

To access this content please accept the following declarations.

This content was selected by and is provided to you upon your unsolicited request courtesy of Novartis with permission of ASH®.